BILL vs TCRX · rev $1.65B vs rev $2.0M
Bill Com Holdings Inc (BILL) versus Tscan Therapeutics Inc (TCRX) — a side-by-side from cached financials, not a winner call.
Bill Com Holdings Inc (BILL) is a software - application company listed on US.
Tscan Therapeutics Inc (TCRX) is a biotechnology company listed on NASDAQ.
Latest reported BILL revenue for 2026-06-30 was $1.65B. Net income was -$11.2M. Revenue was up 13.0% from 2025-06-30 to 2026-06-30. BILL currently screens at market cap $4.78B.
Latest reported TCRX revenue for 2026-06-30 was $2.0M. Net income was -$59.0M. TCRX currently screens at market cap $62.1M.
BILL currently screens at market cap $4.78B. TCRX currently screens at market cap $62.1M.
Not investment advice. Open the BILL and TCRX stock pages for the full models.
Not investment advice.